Back to Agenda
Considerations for the Development and Communication of MSL Metrics
Session Chair(s)
Ed Cunningham, PharmD
Sunovion Pharmaceuticals, Inc., United States
Edith M. Eby, PharmD
Executive Director, Medical Relations and Governance
Pfizer Inc, United States
The role of the Medical Science Liaison (MSL) throughout the phases of a product's life cycle continues to evolve and diversify. While thought leader development is a core activity for MSL teams, additional roles are emerging in areas such as clinical development and managed care clinical support. Regardless of the number or diversity of MSL activities, the optimal metrics for capturing and communicating these activities remain an area of uncertainty. This session discusses concepts involved in measuring and communicating MSL activities, which demonstrate alignment with corporate and Medical objectives while providing value to management and other internal customers.
Speaker(s)
Faculty
Ed Cunningham, PharmD
Sunovion Pharmaceuticals, Inc., United States
Faculty
Edith M. Eby, PharmD
Pfizer Inc, United States
Executive Director, Medical Relations and Governance
Have an account?